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more sensitive than columnar primitive
cells to the noxious effects resulting
from the gastroesophageal reflux and
chronic inflammatory condition, which
likely trigger Barrett’s esophagus (Herfs
et al., 2009)?
If correct, the model presented by
Wang and colleagues would change the
view of metaplasia, shifting the focus of
attention from ‘‘after’’ to ‘‘before the
fact.’’ For further ‘‘conjectures and refuta-
tions,’’ we refer to the authors’ interesting
discussion of the ‘‘competitive or oppor-
tunistic cell replacement mechanism,’’
which may be at the basis of Barrett’sesophagus and other metaplastic condi-
tions with increased cancer risk.
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Transgenerational inheritance of epigenetic states allows organisms to pass on adaptive responses
to the environment to their offspring. Seong et al. (2011) now reveal how stress-induced signaling
through dATF-2 disrupts heterochromatin and leaves heritable marks that influence patterns of
gene expression in subsequent generations.The packing of DNA into condensed and
inaccessible heterochromatin exerts a
powerful influence on the genome, not
only by suppressing transcription but
also by governing proper segregation of
chromosomes during cell division,
silencing transposons and suppressing
illegitimate recombination (Grewal and El-
gin, 2007; Moazed, 2009). Heterochro-
matin nucleation involves the parallel
actions of both the RNA interference
(RNAi) machinery and sequence-specific
DNA-binding proteins, and changes in
the activity of either of these pathways
provide a window of opportunity for chro-
matin states to change without corre-
sponding alterations in DNA sequence.
Such epigenetic changes, if passed to
the next generation, may add an almost
intangible layer of phenotypic variation atan organismal level. Althoughmuch atten-
tion has focused on how environmental
stresses initiate ‘‘a highly programmed
sequence of events within the cell that
serve to cushion the effects of the shock’’
(McClintock, 1984), we are only now
beginning to learn about how stress
modifies chromatin structure, and
whether such stress-induced chromatin
modification is heritable. In this issue,
Seong et al. (2011) show that stress-
induced phosphorylation of the transcrip-
tion factor dATF-2 triggers the loss of
heterochromatin structures at several
regions of the genome in Drosophila, and
that the disrupted heterochromatin state
is transmitted to the next generation in
a non-Mendelian fashion.
Previous work in the fission yeast
Schizosaccharomyces pombe revealedthat the RNAi pathway targets histone H3
lysine 9 (H3K9) methylation and the Swi6
protein (a homologof animalHP1proteins)
to repetitive DNA sequences for hetero-
chromatin assembly at the centromeres
(Volpe et al., 2002). However, in RNAi
mutants, heterochromatin assembly can
still occur at low efficiency. The transcrip-
tion factors Atf1 andPcr1,which belong to
the activating transcription factor/cAMP
response element-binding protein (ATF/
CREB) family of proteins, bind to their
recognition sequences and cooperate
with chromatin-modifying complexes
such as SHREC (SNF2- and histone de-
acetylase-containing repressor complex)
to nucleate and spread heterochromatin
assembly independently at the centro-
meres (Jia et al., 2004). Notably, Atf1
activity is regulated by stress-activated5, June 24, 2011 ª2011 Elsevier Inc. 1005
Figure 1. Stress-Induced Regulation of Heterochromatin Formation
by dATF-2
(A) In low stress conditions, dATF-2 specifically binds to its recognition
sequence CRE (cyclic AMP response element) and likely cooperates with HP1
and chromatin-modifying complexes containing a histone methyltransferase
to nucleate and spread heterochromatin assembly.
(B) Upon heat shock or osmotic stress, dATF-2 is phosphorylated by stress-
activated protein kinases including p38, which in turn leads to release of
phosphorylated dATF-2 from the heterochromatin region. This results in the
disruption of heterochromatin and then increases the expression of genes
located in the region. This epigenetic change is heritable and occurs by
transcommunication between chromosomes.protein kinases (SAPKs), and
it has been long known that
stress induces defects in
heterochromatin assembly
(Jia et al., 2004 and refer-
ences therein).
The Drosophila homolog
(dATF-2) of the fission yeast
Atf1 binds to the cyclic AMP
response element (CRE) and
is phosphorylated by SAPKs
such as p38. Seong and
colleagues (2011) now take
advantage of position effect
variegation (PEV) of white
gene silencing as a read-out
to determine whether dATF-
2 contributes to heterochro-
matin formation in fly. When
a gene is juxtaposed close
to heterochromatin, the inac-
tivating influence of the
heterochromatin can spread
to affect the gene in some,
but not all, cells of the same
cell type. In the white PEV
system, variable spread of
pericentric heterochromatin
gives rise to mottled patterns
of eye pigmentation in which
some cells express the white
gene and are therefore red,
whereas others do not and
are therefore white. Theauthors found that loss of function of
dATF2 induces derepression of the white
gene in the PEV assay system. Indeed,
dATF-2 colocalizes with HP1 on hetero-
chromatin and binds to CREs in hetero-
chromatin. Together, these data show
that CRE-dependent association of
dATF-2 with chromosomes correlates
with heterochromatin formation.
To determine whether environmental
stresses such as heat shock or osmotic
stress could alter the binding of dATF-2
to CREs, and whether such alterations
lead to changes in chromatin state, the
authors examined the phosphorylation
of dATF-2 by SAPKs. Heat shock and
osmotic stress induce the phosphoryla-
tion of dATF-2, which correlates with
a reduction in both the binding of
dATF-2 to CREs located in the pericen-
tromeric heterochromatin and levels of
H3K9 dimethylation at these heterochro-
matic sites (Figure 1). Chromatin immu-
noprecipitation assays in cultured cells1006 Cell 145, June 24, 2011 ª2011 Elsevierreveal that osmotic stress reduces the
levels of H3K9me2 at heterochromatic
sites bound to dATF-2 but not those
bound to a mutant dATF-2, in which the
p38 phosphorylation sites (two threo-
nines) were replaced by alanines, sug-
gesting that disruption of heterochro-
matin by stress is mediated by dATF-2
phosphorylation. The authors also show
that heat shock during early develop-
ment (0–3 hr after egg laying), when
heterochromatin is established, disrupts
heterochromatin formation, which corre-
lates with the release of phosphorylated
dATF-2 from heterochromatic CREs.
This disruption is independent of RNAi-
based mechanisms. Based on these
data, Seong and colleagues (2011) pro-
pose a new model for how stress
induces disruption of heterochromatin:
namely, dATF-2 is required for hetero-
chromatin formation, as in the case for
its fission yeast homolog Atf1, and p38
and its upstream kinase Mekk1 nega-Inc.tively regulate dATF-2-
dependent heterochromatin
formation.
The authors found that the
effectsofstressonheterochro-
matic reporter genes can be
transmitted through the germ-
line. However, the phenotypes
examined (eye color and wing
notches) persist to a lesser
extent in successive genera-
tions and disappear unless
the stress is repeated. Intrigu-
ingly, transgenerational dere-
pression of the white gene
occurs even when unstressed
animals harboring the white
gene are mated with stressed
animals, suggesting that trans-
mission of stress-induced
disruption of heterochromatin
occurs by transcommunica-
tion between chromosomes.
This is reminiscent of paramu-
tation, the temperature-
sensitive process by which
homologous DNA sequences
communicate in trans to
establish meiotically heritable
expression states (Chandler,
2010). Genetic screens in
plants for mutants unable to
undergo paramutation identi-
fied several genes withhomology to genes that mediate RNA-
directed transcriptional silencing, suggest-
ing that the underlying mechanisms
regulating paramutation may be shared
with those of RNAi.
Finally, to examine ‘‘natural’’ target
genes of heterochromatin that are herit-
ably affected by stress, the authors per-
formed a microarray analysis and found
that a number of genes involved in
various biological functions were upregu-
lated in successive generations of stress-
treated flies. We now know that forced
changes to the transcriptome dramati-
cally alter cell fate (for example, in
induced pluripotent stem cells; Takahashi
and Yamanaka, 2006). It will be inter-
esting to discover what happens to the
inheritance of the new epigenetic state
after multiple stress treatments in
successive generations. The work by
Seong and colleagues (2011) opens the
door to studies of how the environment
could influence germ cells in such a way
that epigenetic states and thereby tran-
scriptomes are altered in a directed and
heritable way. The work presents an
interesting example of the Lamarckian
paradigm (Martienssen, 2008; Koonin
and Wolf, 2009), in which the environ-
ment directs evolution, and induced
changes in the epigenetic state may in
turn create variations in gene expression
to be explored, selected for, and co-
opted through the generations.REFERENCES
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The discovery of a small-molecule allosteric inhibitor of the CDC34 ubiquitin-conjugating enzyme
(E2) by Ceccarelli et al. raises the possibility that it will be generally feasible to selectively inhibit
ubiquitin transfer at this central step in the ubiquitin pathway.There is significant interest in targeting
the ubiquitin proteasome system (UPS)
with small molecules for treatment of
diseases such as cancer and neurode-
generation (Bedford et al., 2011). In this
pathway, ubiquitin is transferred to sub-
strates through cycles of an E1-activating
enzyme-E2-conjugating enzyme-E3 ubiq-
uitin ligase cascade, leading to produc-
tion of a polyubiquitin chain covalently
attached to the substrate that targets it
for rapid degradation by the proteasome
(Figure 1A). Though molecules targeting
theE1 class of enzymes aswell as the pro-
teasomeare already in the clinic or in trials,
the development of inhibitors of compo-
nents in the middle of the pathway have
lagged behind. This is despite the fact
that E2s and E3s control the substrate
specificity and the type of ubiquitin linkage
formedand therefore potentially represent
more specific targets for small-molecule-
based therapy. In this issue of Cell, Cec-
carelli et al. (2011) report the identification
of the first inhibitor of an E2 enzyme, in thiscase the human E2 CDC34 (also called
UBE2R1), which plays a critical role in
the elimination of cell-cycle regulatory
proteins by the proteasome (Skaar and
Pagano, 2009). Unexpectedly, the inhib-
itor acts allosterically by binding to a
pocket distant from the active site. This
study indicates that it is possible to
develop a highly selective inhibitor of an
E2 enzyme and raises the possibility of
targeting other E2s in a similar manner.
The success of proteasome inhibitors
clinically has fueled the interest in devel-
oping inhibitors that block specific E1-
E2-E3 pathways (Bedford et al., 2011).
By targeting one or a small number of
E3-dependent processes, the effects on
overall protein homeostasis may be re-
stricted to the precise pathway intended.
CDC34 is one of approximately two dozen
ubiquitin E2s in mammals but is unique in
that it functions solely with one specific
class of E3s: the cullin-RING ligase (CRL).
Cullins employ a RING finger protein
(RBX1orRBX2), togetherwithaconservedpocket in cullins themselves, to recruit
ubiquitin-charged CDC34 (Deshaies and
Joazeiro, 2009; Kleiger et al., 2009). CRL
activity also requires modification of cullin
by the ubiquitin-like NEDD8 protein, a pro-
cess that is inhibited by a small-molecule
inhibitor of the neddylation E1 enzyme
(Figure 1B) (Bedford et al., 2011). As CRLs
are responsible for controlling the turnover
of cancer-relatedgenes, including thecell-
cycle inhibitor p27 (Skaar and Pagano,
2009), this class of E3s has received par-
ticular attention in cancer drug discovery.
To identify small-molecule inhibitors of
p27 ubiquitination, Ceccarelli et al. em-
ployed a fully reconstituted p27 ubiquiti-
nation reaction involving E1, CDC34, the
E3 CRL1SKP2-CKS1, and p27 in a high-
throughput screen, identifying CC0651
as a prime candidate for an inhibitor of
this pathway. Given the number of com-
ponents and thecomplexity of theprocess
being examined in this assay, CC0651
could block one of numerous steps. Using
a variety of related E3CRL complexes and5, June 24, 2011 ª2011 Elsevier Inc. 1007
